Actieve specifieke immunotherapie als adjuvante behandeling van patienten met coloncarcinoom in stadium II of III; prospectief gerandomiseerd onderzoek

Autor: Van Den Eertwegh, A. J.M., Claessen, A. M.E., Van Tinteren, H., Gall, H. E., Meijer, S., Scheper, R. J., Meijer, C. J.L.M., Pinedo, H. M., Vermorken, J. B.

Publikováno v: Van Den Eertwegh, A J M, Claessen, A M E, Van Tinteren, H, Gall, H E, Meijer, S, Scheper, R J, Meijer, C J L M, Pinedo, H M & Vermorken, J B 2000, ' Actieve specifieke immunotherapie als adjuvante behandeling van patienten met coloncarcinoom in stadium II of III; prospectief gerandomiseerd onderzoek ', Nederlands Tijdschrift voor Geneeskunde, vol. 144, no. 6, pp. 274-279 .

Objective. To determine the clinical effect of adjuvant active specific immunotherapy (ASI) with tumour cells and BCG after radical surgery in stage II and stage III colon cancer patients. Design. Prospective randomized controlled clinical trial. Met

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10172::e46b54a3b23d842ed43576ccfab6d3bf
https://research.vumc.nl/en/publications/6e240eda-5b77-4ed1-8303-d7cf5d7201e2

Pharmacokinetic Comparison of Cisplatin in Solution with Common Lyophilized Cisplatinum (Platinol).

Autor: Vermorken, J. B., Van Der Vijgh, W. J. F., Klein, I., Gall, H. E., Splinter, T. A. W., Hart, A. A. M., Pinedo, H. M.

Publikováno v: Therapeutic Drug Monitoring; Sep1986, Vol. 8 Issue 3, p264-268, 5p

Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients.

Autor: Baars A; Department of Medical Oncology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands., Claessen AM, van den Eertwegh AJ, Gall HE, Stam AG, Meijer S, Giaccone G, Meijer CJ, Scheper RJ, Wagstaff J, Vermorken JB, Pinedo HM

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2000 Aug; Vol. 11 (8), pp. 965-70.

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.

Autor: Vermorken JB; Department of Oncology, University Hospital, Antwerp, Belgium., Claessen AM, van Tinteren H, Gall HE, Ezinga R, Meijer S, Scheper RJ, Meijer CJ, Bloemena E, Ransom JH, Hanna MG Jr, Pinedo HM

Publikováno v: Lancet (London, England) [Lancet] 1999 Jan 30; Vol. 353 (9150), pp. 345-50.

Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient.

Autor: Korst AE; University Hospital Vrije Universiteit, Clinical Research Laboratory of Oncology, Amsterdam, The Netherlands., Gall HE, Vermorken JB, van der Vijgh WJ

Publikováno v: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 1996; Vol. 39 (1-2), pp. 162-6.